Your browser doesn't support javascript.
loading
A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU.
Weatherall, Mary; Aantaa, Riku; Conti, Giorgio; Garratt, Chris; Pohjanjousi, Pasi; Lewis, Michael A; Moore, Nicholas; Perez-Gutthann, Susana.
Afiliação
  • Weatherall M; Study Manager, Orion Pharma, PO Box 6792, Nottingham,, NG1 1AH, UK.
  • Aantaa R; Perioperative Services, Intensive care, Emergency Care and Pain Medicine, University of Turku, Turku, Finland.
  • Conti G; Anaesthesia and Intensive Care Medicine, Catholic University of Rome, Rome, Italy.
  • Garratt C; Development Leader, Orion Pharma, PO Box 6792, Nottingham, NG1 1AH, UK.
  • Pohjanjousi P; Biostatistician, Orion Pharma, Volttikatu 8, P.O.Box 1780, 70701, Kuopio, Finland.
  • Lewis MA; EPES Epidemiology GmbH, Wulffstr. 8, D-12165, Berlin, Germany.
  • Moore N; Bordeaux Pharmacoepi, University of Bordeaux, 146 rue Léo Saignat ▪, 33076, Bordeaux cedex, France.
  • Perez-Gutthann S; RTI Health Solutions, Av. Diagonal 605, 9-1, 08028, Barcelona, Spain.
Br J Clin Pharmacol ; 83(9): 2066-2076, 2017 Sep.
Article em En | MEDLINE | ID: mdl-28345249

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexmedetomidina / Uso de Medicamentos / Uso Off-Label Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Dexmedetomidina / Uso de Medicamentos / Uso Off-Label Tipo de estudo: Observational_studies Limite: Female / Humans / Male / Middle aged País como assunto: Europa Idioma: En Ano de publicação: 2017 Tipo de documento: Article